Initiating Febuxostat Therapy with Prophylaxis

Mandatory Anti-Inflammatory Prophylaxis

The American College of Rheumatology strongly recommends initiating anti-inflammatory prophylaxis therapy (colchicine, NSAIDs, or prednisone/prednisolone) over no prophylaxis when starting any urate-lowering therapy, with a preferred prophylactic agent being colchicine 0.5-1 mg daily 1, 2, 3, 4
The 2020 American College of Rheumatology guidelines recommend concomitant anti-inflammatory prophylaxis when initiating febuxostat, which should not be optional 1, 2

The American College of Rheumatology strongly recommends continuing prophylaxis for 3-6 months rather than <3 months, with ongoing evaluation and continued prophylaxis as needed if the patient continues to experience flares 1, 2
The EULAR guidelines recommend prophylaxis during the first 6 months of urate-lowering therapy 3

The American College of Rheumatology strongly recommends starting febuxostat at ≤40 mg/day with subsequent dose titration to target over starting at a higher dose 1, 2
After 2-4 weeks, increase to 80 mg daily if serum urate remains >6 mg/dL, according to Praxis Medical Insights 5

In patients with severe renal impairment, reduce colchicine dose to 0.5 mg daily or consider alternative prophylaxis, as recommended by the Annals of the Rheumatic Diseases 3
Avoid colchicine in patients receiving strong P-glycoprotein and/or CYP3A4 inhibitors (cyclosporine, clarithromycin) due to risk of fatal toxicity, according to the Annals of the Rheumatic Diseases 3

Titrate febuxostat dose to achieve serum urate <6 mg/dL using a treat-to-target strategy, as recommended by Praxis Medical Insights 5
For patients with severe gout (tophi, chronic arthropathy, frequent attacks), consider a lower target of <5 mg/dL until crystal dissolution is complete, according to the Annals of the Rheumatic Diseases and Praxis Medical Insights 3, 5

The American College of Rheumatology recommends starting urate-lowering therapy during active gout flares with concurrent anti-inflammatory treatment, and prednisone serves as appropriate anti-inflammatory prophylaxis during febuxostat initiation 6, 7
The American College of Rheumatology guidelines support strong indications for ULT initiation, including ≥2 gout flares per year, presence of tophi, or radiographic damage from gout, and conditional indications such as >1 previous flare with infrequent attacks, or first flare with CKD stage ≥3, serum urate >9 mg/dL, or urolithiasis 6, 7

If the patient has established cardiovascular disease, the American College of Rheumatology conditionally recommends considering switching to allopurinol instead of febuxostat due to increased CVD-related mortality risk, requiring shared decision-making with patients who have CVD 8

The American College of Rheumatology recommends starting febuxostat during an active gout flare rather than delaying until after the flare resolves, and using prednisone at therapeutic doses to treat the acute inflammatory episode itself 9, 10
For an acute gout flare, prednisone is an effective first-line option at doses of approximately 7.5 mg prednisone equivalent daily, and febuxostat should be started immediately during the flare rather than waiting for resolution, while maintaining anti-inflammatory prophylaxis for 3-6 months 9

Start febuxostat at ≤40 mg daily to minimize flare risk during initiation, as recommended by the American College of Rheumatology 9
The American College of Rheumatology strongly recommends initiating concomitant anti-inflammatory prophylaxis when starting febuxostat, which should not be optional 9

The American College of Rheumatology recommends continuing prophylaxis for 3-6 months after initiating febuxostat, and considering alternative prophylaxis options such as colchicine or NSAIDs if necessary 9, 10
Colchicine 0.5-1 mg daily is a first-line prophylaxis option, and prednisone 7.5 mg daily is an alternative option, as recommended by the American College of Rheumatology 9, 10

Start prednisone 30-40 mg daily to treat the acute flare, and simultaneously initiate febuxostat 40 mg daily during the same visit, as recommended by the American College of Rheumatology 9, 10
Continue prophylactic anti-inflammatory throughout febuxostat titration, and monitor serum urate levels every 2-4 weeks during dose titration, as recommended by the American College of Rheumatology 9, 10